Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesGlucocorticoid-induced osteoporosis: Unawareness or negligence in India?
International Journal of Rheumatic Diseases, 08/20/09
Gera C et al. – This study shows poor pre-therapeutic risk assessment, absence of instructions regarding preventive measures, inappropriate investigation for presence of osteoporosis, and unacceptable absence of bone protective agents in patients receiving long-term glucocorticoid therapy.
Methods- Burden of osteoporosis is on the rise and glucocorticoids are one of the leading causes of drug-induced osteoporosis
- Pts on long-term glucocorticoid therapy should receive adequate prophylaxis to prevent osteoporosis
- This study was undertakent to identify prescribing trends for prophylaxis and management of steroid-induced osteoporosis
- A retrospective audit for pts to determine whether clinicians are evaluating and following prophylactic guidelines for corticoid-induced osteoporosis:
- Information regarding risk assessment for osteoporosis
- Instructions regarding its prevention
- Bone mineral density (BMD) measurements, and
- Prophylactic therapy were recorded
- 105 pts (38 men), >18 yrs of age were included in this study
- 56% had at least 1 documented intervention for osteoporosis prevention (calcium, vit D, bisphosphonates or a BMD study)
- Only 3 pts received bisphosphonates for osteoporosis prophylaxis
Related Articles
Effects of Alendronate on Bone Metabolism in Glucocorticoid-Induced Osteoporosis Measured by 18F-Fluoride PET: A Prospective Study
The Journal of Nuclear Medicine, 11/02/09
Relevance Score: 67%
Teriparatide Outperforms Alendronate In Treating Steroid-induced Osteoporosis
ScienceDaily, 10/30/09
Relevance Score: 67%
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
Arthritis & Rheumatism, 11/03/09
Relevance Score: 66%
Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09
Relevance Score: 46%
Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09
Relevance Score: 45%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
Bone , 12/11/09
The efficacy of calcitriol therapy in the management of bone loss and fractures: A qualitative review
Osteoporosis International, 12/10/09
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: Systematic review and meta-analysis
Osteoporosis International, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor